209 related articles for article (PubMed ID: 34217999)
1. The role of endolysosomal trafficking in anticancer drug resistance.
Hussein NA; Malla S; Pasternak MA; Terrero D; Brown NG; Ashby CR; Assaraf YG; Chen ZS; Tiwari AK
Drug Resist Updat; 2021 Jul; 57():100769. PubMed ID: 34217999
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance.
Zhitomirsky B; Assaraf YG
Oncotarget; 2015 Jan; 6(2):1143-56. PubMed ID: 25544758
[TBL] [Abstract][Full Text] [Related]
3. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
4. Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency.
Zhang J; He J; Johnson JL; Napolitano G; Ramadass M; Rahman F; Catz SD
Autophagy; 2019 Oct; 15(10):1738-1756. PubMed ID: 30892133
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.
Fedele AO; Proud CG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32285908
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells.
You H; Jin J; Shu H; Yu B; De Milito A; Lozupone F; Deng Y; Tang N; Yao G; Fais S; Gu J; Qin W
Cancer Lett; 2009 Jul; 280(1):110-9. PubMed ID: 19299075
[TBL] [Abstract][Full Text] [Related]
7. Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition.
Hraběta J; Belhajová M; Šubrtová H; Merlos Rodrigo MA; Heger Z; Eckschlager T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575682
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling.
Valapala M; Wilson C; Hose S; Bhutto IA; Grebe R; Dong A; Greenbaum S; Gu L; Sengupta S; Cano M; Hackett S; Xu G; Lutty GA; Dong L; Sergeev Y; Handa JT; Campochiaro P; Wawrousek E; Zigler JS; Sinha D
Autophagy; 2014 Mar; 10(3):480-96. PubMed ID: 24468901
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal Fusion: An Efficient Mechanism Increasing Their Sequestration Capacity for Weak Base Drugs without Apparent Lysosomal Biogenesis.
Skoupa N; Dolezel P; Mlejnek P
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947839
[TBL] [Abstract][Full Text] [Related]
10. Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.
Goler-Baron V; Assaraf YG
PLoS One; 2012; 7(4):e35487. PubMed ID: 22530032
[TBL] [Abstract][Full Text] [Related]
11. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.
Wang S; Ni HM; Chao X; Wang H; Bridges B; Kumer S; Schmitt T; Mareninova O; Gukovskaya A; De Lisle RC; Ballabio A; Pacher P; Ding WX
Autophagy; 2019 Nov; 15(11):1954-1969. PubMed ID: 30894069
[TBL] [Abstract][Full Text] [Related]
12. TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy.
Peña-Llopis S; Brugarolas J
Cell Cycle; 2011 Dec; 10(23):3987-8. PubMed ID: 22101272
[No Abstract] [Full Text] [Related]
13. Docetaxel enhances lysosomal function through TFEB activation.
Zhang J; Wang J; Wong YK; Sun X; Chen Y; Wang L; Yang L; Lu L; Shen HM; Huang D
Cell Death Dis; 2018 May; 9(6):614. PubMed ID: 29795139
[TBL] [Abstract][Full Text] [Related]
14. Control of lysosomal biogenesis and Notch-dependent tissue patterning by components of the TFEB-V-ATPase axis in Drosophila melanogaster.
Tognon E; Kobia F; Busi I; Fumagalli A; De Masi F; Vaccari T
Autophagy; 2016; 12(3):499-514. PubMed ID: 26727288
[TBL] [Abstract][Full Text] [Related]
15. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.
Hinton A; Sennoune SR; Bond S; Fang M; Reuveni M; Sahagian GG; Jay D; Martinez-Zaguilan R; Forgac M
J Biol Chem; 2009 Jun; 284(24):16400-16408. PubMed ID: 19366680
[TBL] [Abstract][Full Text] [Related]
16. V-ATPase V0 subunit activation mediates maduramicin-induced methuosis through blocking endolysosomal trafficking in vitro and in vivo.
Zheng Y; Xiao J; Wang J; Dong B; Guo D; Ji H; Sun H; Peng L; Jiang S; Gao X
Food Chem Toxicol; 2023 Aug; 178():113922. PubMed ID: 37394175
[TBL] [Abstract][Full Text] [Related]
17. Oblongifolin C suppresses lysosomal function independently of TFEB nuclear translocation.
Wu M; Lao YZ; Tan HS; Lu G; Ren Y; Zheng ZQ; Yi J; Fu WW; Shen HM; Xu HX
Acta Pharmacol Sin; 2019 Jul; 40(7):929-937. PubMed ID: 30333555
[TBL] [Abstract][Full Text] [Related]
18. Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones.
Al-Akra L; Bae DH; Sahni S; Huang MLH; Park KC; Lane DJR; Jansson PJ; Richardson DR
J Biol Chem; 2018 Mar; 293(10):3562-3587. PubMed ID: 29305422
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
[TBL] [Abstract][Full Text] [Related]
20. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
